The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization.

Nikolaos P E KadoglouEmmanouil KorakasChristos KarkosEirini MaratouIoannis KanonidisPanagiotis PlotasNikolaos PapanasParaskevi MoutsatsouIgnatios IkonomidisVaia A Lambadiari

Published in: Cardiovascular diabetology (2021)

High RBP4 and low adiponectin serum levels are independently associated with PAD presence. In addition, RBP4 is an independent predictor of MACE incidence in symptomatic PAD patients.

Keyphrases

lower limb
end stage renal disease
metabolic syndrome
ejection fraction
chronic kidney disease
newly diagnosed
insulin resistance
peritoneal dialysis
prognostic factors
adipose tissue
coronary artery disease
patient reported outcomes
patient reported